SEQUENT SCIENTIFIC
Back to Cashflow Statement
|
SEQUENT SCIENTIFIC Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-61 Cr | ₹-1.44 Cr | ₹32 Cr | ₹67 Cr | ₹-139 Cr |
What is the latest Cash Flow from Financing Activities ratio of SEQUENT SCIENTIFIC ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-61 Cr |
| Mar2024 | ₹-1.44 Cr |
| Mar2023 | ₹32 Cr |
| Mar2022 | ₹67 Cr |
| Mar2021 | ₹-139 Cr |
How is Cash Flow from Financing Activities of SEQUENT SCIENTIFIC Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-61 Cr | Negative | |
| Mar2024 | ₹-1.44 Cr | Negative | |
| Mar2023 | ₹32 Cr | -52.08 | |
| Mar2022 | ₹67 Cr | Positive | |
| Mar2021 | ₹-139 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹9,749.3 Cr | 3.2% | 12.1% | 24.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,402.0 Cr | 0.5% | -1.5% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,277.0 Cr | 5.5% | -0.2% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,140.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹107,398.0 Cr | 1.3% | -7.9% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,378.0 Cr | 2% | 4.5% | 2.3% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | 3.2% |
12.1% |
24.6% |
| SENSEX | 0.4% |
-0.2% |
6.9% |
You may also like the below Video Courses